Encouraging Calcium Absorption and Bone Formation During Early Puberty
|ClinicalTrials.gov Identifier: NCT00022867|
Recruitment Status : Completed
First Posted : August 16, 2001
Last Update Posted : July 24, 2015
|Condition or disease||Intervention/treatment||Phase|
|Osteoporosis Osteopenia||Drug: Nondigestible oligosaccharide (NDO)||Phase 1 Phase 2|
Rapid increases in bone mass occur during calcium absorption and bone calcium deposition during puberty, and these increases can enhance peak bone mass and ultimately decrease the lifetime risk of osteoporosis. However, dietary, hormonal, and genetic factors likely affect increased bone mass. This study will examine if adding NDO to a pubertal diet allows more absorption of calcium by the body, producing stronger bones. The study will also assess how the hormones produced by the body during puberty affect bone growth and whether genetic factors affect calcium absorption or bone growth.
This study will last 2 years. At study entry, baseline pubertal hormone levels and bone mass will be assessed. Both a dual-energy X-ray absorptiometry (DEXA) scan and a calcium stable kinetic study measuring calcium absorption will be performed. Participants will then be randomly assigned to receive calcium fortified food with or without added NDO for 1 year. Calcium absorption will be measured again at 2 months. After the first year, calcium kinetic, hormonal, and DEXA studies will be performed and compared to baseline results. A final DEXA scan will be performed at the end of 2 years.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Optimization of Calcium Absorption and Bone Formation During Early Puberty|
|Study Start Date :||May 2001|
|Actual Primary Completion Date :||January 2005|
|Actual Study Completion Date :||November 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00022867
|United States, Texas|
|Children's Nutrition Research Center at Baylor College of Medicine|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Steven A. Abrams, MD||Baylor College of Medicine|